These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 226095)

  • 1. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA.
    Goswami BB; Borek E; Sharma OK; Fujitaki J; Smith RA
    Biochem Biophys Res Commun; 1979 Aug; 89(3):830-6. PubMed ID: 226095
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
    Kaiser WA; Herrmann B; Keppler DO
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to inhibition of viral replication: inhibition of mRNA methylation.
    Goswami BB; Sharma OK; Borek E
    Recent Results Cancer Res; 1983; 84():275-82. PubMed ID: 6302749
    [No Abstract]   [Full Text] [Related]  

  • 4. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.
    Eriksson B; Helgstrand E; Johansson NG; Larsson A; Misiorny A; Norén JO; Philipson L; Stenberg K; Stening G; Stridh S; Oberg B
    Antimicrob Agents Chemother; 1977 Jun; 11(6):946-51. PubMed ID: 879760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme.
    Bougie I; Bisaillon M
    J Biol Chem; 2004 May; 279(21):22124-30. PubMed ID: 15037606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sindbis virus mutants resistant to mycophenolic acid and ribavirin.
    Scheidel LM; Durbin RK; Stollar V
    Virology; 1987 May; 158(1):1-7. PubMed ID: 3033882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
    Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
    Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin induced differentiation of murine erythroleukemia cells.
    Kerr SJ
    Mol Cell Biochem; 1987 Oct; 77(2):187-94. PubMed ID: 3481433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis.
    Wray SK; Gilbert BE; Noall MW; Knight V
    Antiviral Res; 1985 Feb; 5(1):29-37. PubMed ID: 3985606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells.
    Natsumeda Y; Yamada Y; Yamaji Y; Weber G
    Biochem Biophys Res Commun; 1988 May; 153(1):321-7. PubMed ID: 2897852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.
    Müller WE; Maidhof A; Taschner H; Zahn RK
    Biochem Pharmacol; 1977 Jun; 26(11):1071-5. PubMed ID: 880258
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin.
    Murphy MF
    J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and specificity of action of ribavirin.
    Browne MJ
    Antimicrob Agents Chemother; 1979 Jun; 15(6):747-53. PubMed ID: 475358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible inhibition of cellular metabolism by ribavirin.
    Larsson A; Stenberg K; Oberg B
    Antimicrob Agents Chemother; 1978 Feb; 13(2):154-8. PubMed ID: 646339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of adenylyl-(3'--5') guanosine-stimulated virion RNA polymerase from influenza A virus by means of adenylyl-(3'--5') virazole].
    Galegov GA; Pravdina NF
    Vopr Virusol; 1982; 27(5):104-6. PubMed ID: 7147892
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopharmacological studies of ribavirin, a broad-spectrum antiviral agent.
    Borghi C; Allegrucci M; Ballerini P; Bianchi R; Puccetti P; Romani L; Fioretti MC
    Chemioterapia; 1987 Jun; 6(2 Suppl):660-3. PubMed ID: 3509519
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin).
    Katz E; Margalith E; Winer B
    J Gen Virol; 1976 Aug; 32(2):327-30. PubMed ID: 1018177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.